Literature DB >> 139034

[The so-called sweat-gland carcinoma of the human breast. A review (author's transl)].

H Hamperl.   

Abstract

The term sweat-gland carcinoma of the breast is used in widely different meanings. Nonetheless, two histologically well-characterized types may be recognized: 1. The apocrine (oncocytic) carcinoma is composed of large well-delimited cells with finely granular, oxyphilic cytoplasm similar to that of oncocytes of other organs. They resemble the "pale" oxyphilic cells of the aging normal breast whose cytoplasm in part show the same quality. These carcinoma cells are regarded as mammary cells in a state of transition into oncocytes. Any similarity they have to cells of the apocrine axillary sweat-gland is purely superficial and in no way influences the interpretation of apocrine carcinomas. 2. The secreting carcinoma histologically is reminiscent of the functioning, hormonally stimulated breast of pregnancy. It reveals apocrine extrusion of nuclei and an accumulation of neutral fat in cytoplasm and duct lumina. A case of secreting carcinoma is described in detail to exemplify the association with exogenous hormonal stimulation. Both types of differentiation of carcinomas may arise together or with other types of mammary carcinomas, and share the clinical prognosis with them. The term sweat-gland carcinoma of the human breast should be abolished since there exists no proof that they really occur.

Entities:  

Mesh:

Year:  1977        PMID: 139034     DOI: 10.1007/bf00284119

Source DB:  PubMed          Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol        ISSN: 0084-5353


  24 in total

1.  Apocrine metaplasia in cystic hyperplastic mastopathy. Histochemical and ultrastructural observations.

Authors:  A Ahmed
Journal:  J Pathol       Date:  1975-04       Impact factor: 7.996

2.  Comparative Studies of Cancerous Versus Noncancerous Breasts.

Authors:  F W Foote; F W Stewart
Journal:  Ann Surg       Date:  1945-02       Impact factor: 12.969

3.  Histological and histochemical alterations in the normal breast tissues of patients with advanced breast cancer being treated with estrogenic hormones.

Authors:  R A HUSEBY; L B THOMAS
Journal:  Cancer       Date:  1954-01       Impact factor: 6.860

4.  Breast cancer during oral contraceptive therapy.

Authors:  R E Fechner
Journal:  Cancer       Date:  1970-12       Impact factor: 6.860

5.  Pink cell (oncocytic) metaplasia in a fibro-adenoma of the human breast: electron-microscope observations.

Authors:  F Archer; M Omar
Journal:  J Pathol       Date:  1969-10       Impact factor: 7.996

6.  The ultrastructure of apocrine cells in intracystic papilloma and fibrocystic disease of the breast.

Authors:  W J Pier; J C Garancis; J F Kuzma
Journal:  Arch Pathol       Date:  1970-05

7.  Fibrocystic disease in women receiving oral contraceptive hormones.

Authors:  R E Fechner
Journal:  Cancer       Date:  1970-06       Impact factor: 6.860

8.  [Oncocytes and hyaline inclusions in the human breast].

Authors:  H Hamperl
Journal:  Virchows Arch B Cell Pathol       Date:  1972

9.  The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4).

Authors:  E R Fisher; R M Gregorio; B Fisher; C Redmond; F Vellios; S C Sommers
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860

10.  The cytology of apocrine sweat glands. II. Human.

Authors:  B L Munger
Journal:  Z Zellforsch Mikrosk Anat       Date:  1965-12-30
View more
  3 in total

1.  Histologic variants of lipid-secreting carcinoma of the breast.

Authors:  L J van Bogaert; P Maldague
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-10-07

2.  Invasive apocrine carcinoma of the breast: a long term follow-up study of 34 cases.

Authors:  E S d'Amore; M J Terrier-Lacombe; J P Travagli; S Friedman; G Contesso
Journal:  Breast Cancer Res Treat       Date:  1988-09       Impact factor: 4.872

3.  Apocrine carcinoma of the breast. A morphologic and immunocytochemical study.

Authors:  V Eusebi; R R Millis; M G Cattani; G Bussolati; J G Azzopardi
Journal:  Am J Pathol       Date:  1986-06       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.